Ken Griffin Sunshine Biopharma Inc Wt Exp Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sunshine Biopharma Inc Wt Exp stock. As of the latest transaction made, Citadel Advisors LLC holds 41,431 shares of SBFMW stock, worth $9,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,431

Previous 45,131 8.2%

Holding current value

$9,114

Previous $4,000 50.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.08 - $0.34 $296 - $1,258	-3,700 Reduced 8.2%	41,431 $6,000
Q3 2024 Nov 14, 2024	SELL	$0.05 - $0.24 $1,161 - $5,577	-23,239 Reduced 33.99%	45,131 $4,000
Q2 2024 Aug 14, 2024	BUY	$0.05 - $0.18 $62 - $225	1,255 Added 1.87%	68,370 $4,000
Q1 2024 May 15, 2024	BUY	$0.04 - $0.3 $219 - $1,645	5,485 Added 8.9%	67,115 $3,000
Q4 2023 Feb 14, 2024	SELL	$0.12 - $0.29 $507 - $1,225	-4,226 Reduced 6.42%	61,630 $12,000
Q3 2023 Nov 14, 2023	BUY	$0.17 - $0.5 $5,900 - $17,354	34,708 Added 111.43%	65,856 $14,000
Q2 2023 Aug 14, 2023	BUY	$0.31 - $0.68 $9,655 - $21,180	31,148 New	31,148 $11,000

Others Institutions Holding SBFMW

# of Institutions

Shares Held

57.7K

Call Options Held

Put Options Held

View Full List

About SUNSHINE BIOPHARMA INC WT EXP

Ticker SBFMW
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic

More about SBFMW

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account